Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a version label update rather than a change to study content or site navigation.SummaryDifference0.0%

- Check39 days agoChange DetectedMinor site revision update from v3.4.0 to v3.4.1 with no impact on the study page content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedGlossary visibility controls (Show glossary / Hide glossary) were added, wording tweaks include Last Update Submitted that Met QC Criteria and No FEAR Act Data, and the revision version was bumped to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No user-visible changes to the Study Details page were observed.SummaryDifference0.0%

- Check90 days agoChange DetectedA new Locations section with listed study sites in the United States, Canada, and Hungary (including Bekes County and Hajdú-Bihar) was added, and the page revision tag was updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.